Yu Zhiyong, Zhou Jie, Xie Xiaojun, Li Xuan, Wu Yijun
Department of Thyroid Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Department of Pathology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Gland Surg. 2025 May 30;14(5):938-946. doi: 10.21037/gs-2025-156. Epub 2025 May 27.
Surgery is the definitive treatment for primary hyperparathyroidism (PHPT). However, surgical outcomes can be affected by numerous factors, some of which are still a matter of debate. We examined cases at the First Affiliated Hospital of Zhejiang University, and assessed the risk factors affecting surgical success and postoperative recurrence.
We conducted a retrospective analysis of the clinical data of patients who underwent surgery for PHPT without intraoperative parathyroid hormone (IOPTH) monitoring at the First Affiliated Hospital of Zhejiang University between August 2017 and June 2022. We analyzed the surgical success rates, recurrence rates, and persistent disease rates, and performed univariate and multivariate analyses to identify the risk factors associated with surgical success and postoperative recurrence/persistent lesions.
The overall surgical success rate was 97.8%, and the postoperative recurrence rate was 8.2%. Univariate analysis confirmed that a higher level of preoperative parathyroid hormone (PTH) and blood calcium is associated with a lower success rate of surgery (P<0.05). However, the multivariate analysis did not reveal any significance in them. The univariate analysis identified preoperative target organ damage, urolithiasis, and preoperative alkaline phosphatase (ALP), PTH, and phosphorus levels as risk factors for postoperative recurrence/persistent lesions (P<0.05). The multivariate analysis revealed that only the phosphorus level was a significant risk factor for postoperative recurrence/persistent lesions (P<0.05). The receiver operating characteristic (ROC) curve analysis indicated that phosphorus levels below 0.865 mmol/L were associated with a higher incidence of recurrence/persistent lesions, and had a sensitivity of 0.718 and a specificity of 0.67.
In PHPT, satisfactory surgical success rates can be achieved without IOPTH monitoring. The blood phosphorus level is a significant predictor of postoperative recurrence or persistent lesions, and thus could guide clinical decision making.
手术是原发性甲状旁腺功能亢进症(PHPT)的确定性治疗方法。然而,手术结果会受到多种因素影响,其中一些因素仍存在争议。我们研究了浙江大学第一附属医院的病例,并评估了影响手术成功及术后复发的危险因素。
我们对2017年8月至2022年6月在浙江大学第一附属医院接受PHPT手术且未进行术中甲状旁腺激素(IOPTH)监测的患者临床资料进行回顾性分析。我们分析了手术成功率、复发率和持续性疾病率,并进行单因素和多因素分析以确定与手术成功及术后复发/持续性病变相关的危险因素。
总体手术成功率为97.8%,术后复发率为8.2%。单因素分析证实,术前甲状旁腺激素(PTH)和血钙水平较高与手术成功率较低相关(P<0.05)。然而,多因素分析未显示它们具有任何显著性。单因素分析确定术前靶器官损害、尿路结石以及术前碱性磷酸酶(ALP)、PTH和磷水平为术后复发/持续性病变的危险因素(P<0.05)。多因素分析显示,只有磷水平是术后复发/持续性病变的显著危险因素(P<0.05)。受试者工作特征(ROC)曲线分析表明,磷水平低于0.865 mmol/L与复发/持续性病变的发生率较高相关,其敏感性为0.718,特异性为0.67。
在PHPT中,不进行IOPTH监测也可获得满意的手术成功率。血磷水平是术后复发或持续性病变的重要预测指标,因此可指导临床决策。